New Delhi [India], November 16 (ANI/PRNewswire): Orchid Pharma today announced their Q2'22 results. Fuelled by increasing sales and a laser-sharp focus on costs, Orchid Pharma reported a 36 per cent surge in total revenue from operations while the EBIDTA has jumped by 104 per cent over the q